BrainsWay Ltd. (NASDAQ:BWAY) stock is trading higher on Monday after the company announced a $20 million investment from Valor Equity Partners.

The Details: BrainsWay will issue a total of 2,103,745 American Depositary Shares (ADSs) at a purchase price of $9.51 per share, representing a 20% premium over the average ADSs price during the past 30 days.

The company said it plans to use the proceeds from the PIPE for initiatives including expanding market awareness, enhancing data analysis capabilities, developing its R&D roadmap, evaluating other potential opportunities in the TMS industry and expanding access to Deep TMS.

If Valor maintains at least 10% of BrainsWay's outstanding voting rights, it can nominate one member to BrainsWay's board of directors. If Valor maintains at least 20%, it will have the right to nominate two members to the board.

"The equity financing strengthens the Company's balance sheet, further advances strategic initiatives, and expands access to its Deep TMS technology, while aligning BrainsWay with a premier U.S. tech investor," said Ami Boehm, the company's Chairman of the board.

How To Buy BrainsWay Shares

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in BrainsWay (NASDAQ:BWAY)'s case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

BWAY Price Action: At the time of writing, BrainsWay shares are trading 14.6% higher at $9.25, according to data from Benzinga Pro.

Image: 6690186 from Pixabay.